Skip to main content
Caplight Logo









Abselion

Abselion

Private
CambridgeHealthcare & Life Scienceshttps://www.abselion.com/

Last Round

Series A

Dec 4, 2024

Total Funding Raised

$11.05M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Abselion is a life sciences tools company that develops and manufactures automated analytical instruments for protein quantification.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

gene therapyAAV quantificationviral vectorbioprocessingAdeno-Associated VirusAAVanalytical instrumentationbiotech toolsRedox Electrochemical DetectionREDbioprocess analyticsCDMOcontract manufacturingat-line monitoringbiotech lab tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abselion Comparables

Compare Abselion with similar companies based on industry and business-model similarity.

Abselion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Refeyn
79%
Mesa Laboratories Inc
74%
Thermo Fisher Scientific Inc.
73%

Abselion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 4, 2024
SeedApr 20, 2021
GrantSep 11, 2018

Key People

Founding team and executive leadership

Ruizhi Wang

Founder and CEO

Founding Team

Abselion Investors

Notable investors and investment history

Abselion investors
InvestorRounds
NG BioSeed
Swiss Health AngelsSeed
The Untitled venturesSeries A
BGFSeries A
M VenturesSeries A
Cambridge EnterpriseSeed
R42 GroupSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 354% MoM, from 323 to 1.5K.

  • Mar 23, 2026

    Dale Gordon appointed as Chair of the Board of Directors.

Abselion Filings

Explore SEC and related filing metadata, where available.

Abselion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abselion's valuation, stock price, and market status.

Is Abselion a public or private company?

Abselion is a private company.

What is the current stock price of Abselion?

Abselion is a private company with no public stock price. No recent secondary market data is available.

How much is Abselion worth (valuation)?

Valuation information for Abselion is not publicly available.

Can I buy Abselion stock?

Abselion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abselion's last funding round?

Abselion's most recent funding round was Series A on December 4, 2024.

Who are the main investors in Abselion?

Key investors in Abselion include M Ventures, Cambridge Enterprise.

Will Abselion IPO soon?

No public IPO plans have been announced for Abselion.

How can I track Abselion secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abselion's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range21
Year Founded2018
Last FundingDec 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?